Search clinical trials for: JNJ-55308942: Fed State

Total 45 results

Janssen-Cilag International NV

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55308942 in Healthy Male and Female Participants

Healthy

Belgium
Konkuk University Medical Center
Daewoong Pharmaceutical Co. LTD.

Recruiting

Treatment Effect According to Timing of Administration of DWP14012 40 mg

Erosive Esophagitis

Korea, Republic of
GlaxoSmithKline

Completed

Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers

Cancer

Australia
Daewoong Pharmaceutical Co. LTD.
Hanyang University

Unknown

Treatment Effect According to Timing of Administration of DWP14012 40 mg

Erosive Esophagitis

Korea, Republic of
Sunshine Lake Pharma Co., Ltd.

Completed

Clifutinib Food Effect Study in Healthy Subjects

Acute Myeloid Leukemia in Children

China
KU Leuven

Unknown

Gastrointestinal Behavior of Posaconazol in Healthy Volunteers

Healthy

Belgium
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Recruiting

Changes in Inhibition and Valuation After Eating

Bulimia Nervosa

United States
Abbisko Therapeutics Co, Ltd

Not yet recruiting

ABSK021 Food Effect Study in Healthy Subjects

Neoplasms
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Recruiting

Self-Control in Bulimia Nervosa

Bulimia Nervosa

United States
Pfizer

Completed

Relative Bioavailability Study of a Modified-Release Formulation of PF-06865571 in Healthy Adult Participants

Healthy Participants

Belgium
Manchester Metropolitan University
European Society for Clinical Nutrition and Metabolism

Recruiting

Role of Fasted Exercise on Improving Cardiometabolic Health

Cardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2

United Kingdom
National Institute of Cardiology, Laranjeiras,...

Withdrawn

Microvascular and Metabolic Effects of High-intensity Interval Exercise Training (HIIT-FAST)

Obesity | Overweight | Physical Activity

Brazil
Universitaire Ziekenhuizen KU Leuven

Completed

Gastrointestinal Physiological Conditions in Obesity and After Bariatric Surgery (GASTON)

Obesity | Bariatric Surgery Candidate

Belgium
Janssen Research & Development, LLC

Completed

Effect of Food on a Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release in Healthy Volunteers

Healthy
Janssen-Cilag International NV

Completed

A Positron Emission Tomography (PET) Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-JNJ-64413739

Healthy

Belgium
Vanderbilt University
Vanderbilt University Medical Center

Completed

Putative Cognitive Enhancer VU319

Cognitive Impairment

United States
Janssen Research & Development, LLC

Withdrawn

Study to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076 in Healthy Participants

Healthy

United States
Janssen Pharmaceutica N.V., Belgium

Recruiting

A Study of JNJ-55308942 in the Treatment of Bipolar Depression

Bipolar Disorder

United States, Spain, Poland, Canada
GlaxoSmithKline

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia

Australia
Federal University of Rio Grande do Sul

Completed

Resistance Training in the Fasted State

Exercise | Fasting | Resistance Training

Brazil
Janssen Research & Development, LLC

Withdrawn

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic Function

Hepatic Impairment
GlaxoSmithKline

Completed

A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. (P1A114919)

Multiple Sclerosis, Relapsing-Remitting

Australia
AstraZeneca

Completed

Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants

Type 2 Diabetes Mellitus

United States
University of Oxford
Wellcome Trust

Recruiting

A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes (MIST2)

Plasmodium Vivax Infection

Thailand
Children's Hospital Medical Center, Cincinnati
National Institutes of Health (NIH)

Completed

STAT-ED: Suicidal Teens Accessing Treatment After an Emergency Department Visit (STAT-ED)

Suicide

United States
Janssen-Cilag International NV

Completed

A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol

Healthy

Belgium
Akebia Therapeutics

Completed

Relative Bioavailability of Two Formulations of AKB-6548 and the Food Effect of a New Tablet in Healthy Adult Subjects

Healthy

United States
Mundipharma Research Limited

Completed

A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication

Pain

United Kingdom
Rennes University Hospital
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Recruiting

fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating (Cemov)

Hyperphagia

France
Janssen Research & Development, LLC

Completed

A Study to Assess the Effect of Food on the Bioavailability of Mebendazole From a Fast-Disintegrating Chewable Formulation of Mebendazole in Healthy Participants

Healthy

Belgium
University of Utah

Completed

Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)

Ocular Graft Versus Host Disease

United States
Children's Hospital of Philadelphia
National Institute of Mental Health (NIMH); University of Pennsylvania

Recruiting

Navigating Mental Health Treatment for Black Youth

Suicidal Ideation | Adolescent Behavior

United States
Asan Medical Center

Not yet recruiting

Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer

Gynecologic Cancer

Korea, Republic of
Eisai Co., Ltd.

Completed

A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects

Healthy Subjects

Japan
Janssen Research & Development, LLC

Active, not recruiting

Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer (CHRYSALIS)

Non-Small-Cell Lung Cancer

United States, France, Taiwan, United Kingdom, China, Spain, Japan, Australia, Korea, Republic of, Canada
Janssen Pharmaceutica N.V., Belgium

Terminated

A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat When Administered as a Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared to the Co-administration of the Separate Agents

Healthy

Netherlands
Allena Pharmaceuticals
BDD Pharma Ltd

Completed

Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets

Hyperuricemia | Gout

United Kingdom
KU Leuven

Unknown

The Use of a Non-absorbable Marker for the Evaluation of the Gastrointestinal Transit

Concentration-Time Profiles in Stomach & Intestine.

Belgium
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma

United States
University of Athens
KAT Hospital of Athens

Completed

Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty

Total Hip and Knee Arthroplasties

Greece
Jonsson Comprehensive Cancer Center
Janssen Inc.

Active, not recruiting

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

Recurrent Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation

United States
AbbVie (prior sponsor, Abbott)
Abbott Japan Co.,Ltd

Completed

Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease

Advanced Parkinson's Disease
The Netherlands Cancer Institute
Bristol-Myers Squibb; Eli Lilly and Company; Bayer; GlaxoSmithKline; Merck Sharp... and other collaborators

Recruiting

The Drug Rediscovery Protocol (DRUP Trial) (DRUP)

Cancer | Neoplasm | Tumors | Neoplasia

Netherlands
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8

United States
Vanderbilt University Medical Center
UMC Utrecht

Completed

Decision Support for Intraoperative Low Blood Pressure

Hypotension

United States

Search clinical trials for: JNJ-55308942: Fed State

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations